Suppr超能文献

儿科门诊患者的药物不良反应和超说明书用药

Adverse drug reactions and off-label drug use in paediatric outpatients.

作者信息

Horen Benjamin, Montastruc Jean-Louis, Lapeyre-Mestre Maryse

机构信息

Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et dInformations sur le médicament, Faculté de Médecine.

出版信息

Br J Clin Pharmacol. 2002 Dec;54(6):665-70. doi: 10.1046/j.1365-2125.2002.t01-3-01689.x.

Abstract

AIMS

To investigate the potential relationship between off-label drug use and increased risk of adverse drug reactions in paediatric outpatients.

METHODS

A prospective pharmacovigilance survey of drug prescribing in office based paediatricians was carried out in Haute-Garonne County (south west of France).

RESULTS

The study involved a sample of 1419 children under 16 years old. Forty-two percent of patients were exposed to at least one off-label prescription. The incidence of adverse drug reactions was 1.41% (95% CI 0.79, 2.11). Off-label drug use was significantly associated with adverse drug reactions (relative risk 3.44; 95% CI 1.26, 9.38), particularly when it was due to an indication different than that defined in the Summary Product Characteristics (relative risk 4.42; 95% CI 1.60, 12.25).

CONCLUSIONS

Our data suggest an increasing risk of adverse drug reactions related to off-label drug use. This risk would be acceptable if further studies prove the potential benefit of such a drug use.

摘要

目的

调查儿科门诊患者中使用未标明适应证药物与药物不良反应风险增加之间的潜在关系。

方法

在法国西南部上加龙省开展了一项针对在诊所工作的儿科医生所开处方的前瞻性药物警戒调查。

结果

该研究纳入了1419名16岁以下儿童样本。42%的患者至少接受过一次未标明适应证的处方。药物不良反应发生率为1.41%(95%置信区间0.79,2.11)。使用未标明适应证药物与药物不良反应显著相关(相对风险3.44;95%置信区间1.26,9.38),特别是当适应证与药品说明书中规定的不同时(相对风险4.42;95%置信区间1.60,12.25)。

结论

我们的数据表明,与使用未标明适应证药物相关的药物不良反应风险在增加。如果进一步研究证明这种用药方式有潜在益处,那么这种风险是可以接受的。

相似文献

1
Adverse drug reactions and off-label drug use in paediatric outpatients.
Br J Clin Pharmacol. 2002 Dec;54(6):665-70. doi: 10.1046/j.1365-2125.2002.t01-3-01689.x.
2
Off-label prescribing in pediatric outpatients.
Pediatrics. 2015 Jan;135(1):49-58. doi: 10.1542/peds.2014-0764. Epub 2014 Dec 15.
3
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Curr Drug Saf. 2018;13(3):200-207. doi: 10.2174/1574886313666180619120406.
4
Off label and unlicensed drug use among French office based paediatricians.
Arch Dis Child. 2000 Dec;83(6):502-5. doi: 10.1136/adc.83.6.502.
5
The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Drug Saf. 2004;27(13):1059-67. doi: 10.2165/00002018-200427130-00006.
6
Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Eur J Clin Pharmacol. 2011 May;67(5):449-61. doi: 10.1007/s00228-010-0978-z. Epub 2011 Jan 18.
7
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
Acta Paediatr. 1999 Sep;88(9):965-8. doi: 10.1080/08035259950168469.
8
Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Eur J Clin Pharmacol. 2003 Mar;58(11):779-83. doi: 10.1007/s00228-003-0560-z. Epub 2003 Feb 22.
9
Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Curr Clin Pharmacol. 2017;12(1):18-25. doi: 10.2174/1574884712666170317161935.

引用本文的文献

4
Pediatric-Specific Drug Loss Issue in Japan: Comparison of Pediatric Development Status Between Japan and the United States.
Ther Innov Regul Sci. 2025 Jan;59(1):142-149. doi: 10.1007/s43441-024-00714-6. Epub 2024 Oct 23.
5
[Off-label use of intravenous immunoglobulin g in a highly complex pediatric hospital in Argentina. A prospective observational study].
Rev Fac Cien Med Univ Nac Cordoba. 2024 Jun 28;81(2):254-269. doi: 10.31053/1853.0605.v81.n2.42261.
7
Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
BMC Pediatr. 2024 May 18;24(1):344. doi: 10.1186/s12887-024-04803-1.
9
10
Systematic Review of Early Phase Pediatric Clinical Pharmacology Trials.
J Pediatr Pharmacol Ther. 2022;27(7):609-617. doi: 10.5863/1551-6776-27.7.609. Epub 2022 Sep 26.

本文引用的文献

1
The use of newly marketed drugs in children and adolescents prescribed in general practice.
Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S37-45. doi: 10.1002/(sici)1099-1557(199904)8:1+<s37::aid-pds400>3.3.co;2-0.
2
Frequency of adverse drug reactions in children: a prospective study.
Br J Clin Pharmacol. 2002 Feb;53(2):207-10. doi: 10.1046/j.0306-5251.2001.01535.x.
3
Unlicensed and off-label drug use in children: implications for safety.
Drug Saf. 2002;25(1):1-5. doi: 10.2165/00002018-200225010-00001.
4
A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
Pediatrics. 2001 Nov;108(5):1089-93. doi: 10.1542/peds.108.5.1089.
6
Drug prescribing among Danish children: a population-based study.
Eur J Clin Pharmacol. 2001 May;57(2):159-65. doi: 10.1007/s002280100279.
7
A novel scheme for the reporting of adverse drug reactions.
Arch Dis Child. 2001 Apr;84(4):337-9. doi: 10.1136/adc.84.4.337.
8
Off label and unlicensed drug use among French office based paediatricians.
Arch Dis Child. 2000 Dec;83(6):502-5. doi: 10.1136/adc.83.6.502.
9
Unlicensed and off label prescribing of drugs in general practice.
Arch Dis Child. 2000 Dec;83(6):498-501. doi: 10.1136/adc.83.6.498.
10
Adverse drug reactions in children reported by means of the yellow card in Spain.
J Clin Epidemiol. 2000 Oct;53(10):1076-80. doi: 10.1016/s0895-4356(00)00190-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验